Zentalis is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics.ÊFoundedÊinÊ2014,ÊZentalis PharmaceuticalsÊis backed by investors that includeÊEventide Asset Management, Perceptive Advisors, Redmile Group, Surveyor Capital, and Viking Global InvestorsÊand is headquartered inÊNew York.